Y Intercept Hong Kong Ltd Buys New Shares in Liquidia Corporation $LQDA

Y Intercept Hong Kong Ltd acquired a new stake in shares of Liquidia Corporation (NASDAQ:LQDA) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 62,235 shares of the company’s stock, valued at approximately $775,000. Y Intercept Hong Kong Ltd owned about 0.07% of Liquidia as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the stock. GAMMA Investing LLC increased its stake in shares of Liquidia by 65.6% in the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company’s stock valued at $44,000 after purchasing an additional 1,173 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Liquidia by 2.9% in the 1st quarter. Bank of New York Mellon Corp now owns 194,131 shares of the company’s stock valued at $2,863,000 after purchasing an additional 5,547 shares in the last quarter. Significant Wealth Partners LLC increased its stake in shares of Liquidia by 14.1% in the 1st quarter. Significant Wealth Partners LLC now owns 14,396 shares of the company’s stock valued at $212,000 after purchasing an additional 1,780 shares in the last quarter. Bleakley Financial Group LLC increased its stake in shares of Liquidia by 6.4% in the 1st quarter. Bleakley Financial Group LLC now owns 25,308 shares of the company’s stock valued at $373,000 after purchasing an additional 1,523 shares in the last quarter. Finally, Cetera Investment Advisers increased its stake in shares of Liquidia by 34.4% in the 1st quarter. Cetera Investment Advisers now owns 41,999 shares of the company’s stock valued at $619,000 after purchasing an additional 10,756 shares in the last quarter. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Wells Fargo & Company assumed coverage on Liquidia in a research note on Monday, October 20th. They issued an “overweight” rating and a $31.00 price target for the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a report on Wednesday, October 8th. Jefferies Financial Group reiterated a “buy” rating and issued a $45.00 price objective on shares of Liquidia in a report on Monday. Needham & Company LLC lifted their price objective on Liquidia from $36.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, BTIG Research reiterated a “buy” rating and issued a $49.00 price objective on shares of Liquidia in a report on Tuesday. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $38.56.

Insider Activity

In other Liquidia news, Director Raman Singh sold 45,524 shares of the company’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $25.81, for a total value of $1,174,974.44. Following the completion of the transaction, the director owned 31,255 shares in the company, valued at $806,691.55. This represents a 59.29% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Rajeev Saggar sold 20,000 shares of the company’s stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of $27.85, for a total transaction of $557,000.00. Following the completion of the sale, the insider directly owned 249,727 shares of the company’s stock, valued at $6,954,896.95. The trade was a 7.41% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 849,141 shares of company stock valued at $23,584,920. Insiders own 26.50% of the company’s stock.

Liquidia Stock Down 5.3%

LQDA stock opened at $26.42 on Thursday. The firm has a market cap of $2.30 billion, a PE ratio of -18.35 and a beta of 0.12. The company has a debt-to-equity ratio of 6.19, a quick ratio of 2.41 and a current ratio of 2.20. The firm’s 50 day moving average price is $24.56 and its 200-day moving average price is $19.66. Liquidia Corporation has a one year low of $9.71 and a one year high of $29.94.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Monday, November 3rd. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.45) by $0.41. The company had revenue of $54.34 million for the quarter, compared to analyst estimates of $18.86 million. Liquidia had a negative return on equity of 296.78% and a negative net margin of 176.04%.The company’s revenue was up 1106.7% on a year-over-year basis. On average, equities research analysts anticipate that Liquidia Corporation will post -1.51 EPS for the current year.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).